Protein Biomarkers Overview
With some therapeutics proving ineffective in as many as 75% of patients, the need for precision medicine is clear, as is the benefit of using selection biomarkers in the drug development process where success rates can triple. In the era of personalized and precision medicine, we have expanded our portfolio beyond the routine safety and efficacy parameters in order to deliver value. We are committed to providing a full repertoire of next-generation assays.
Cerba Research can provide either targeted approaches or broad immune profiling and multifactorial biomarker approaches to identify one or a variety of biomarkers, depending on the stage of your clinical trial and the purpose of the biomarker.
To find out more from our library, click here
Find out more by downloading our Protein Biomarkers overview.